NEW YORK — Centinel Spine, Inc. (Centinel), a market leader in the development, manufacture and distribution of Integrated Interbody Fusion™ devices, today announced a record 41.8% revenue increase during the 4th quarter, 2010, vs. 3rd quarter, 2010. Also, during the 4th quarter, 2010, Centinel achieved a record setting 32.5% gain vs. the same period in 2009.
Announcing the results, Centinel’s Chairman and CEO, John J. Viscogliosi, said, “We are extremely pleased, but certainly not surprised, by Q4’s huge revenue increase and record results. A confluence of positive events continued for us in the 4th quarter as we initiated our new STALIF MIDLINE™ alpha launch, while support from surgeons using our STALIF C™ and STALIF TT™ Integrated Interbody fusion devices continued on an exponential growth path. Looking forward, we fully expect the first quarter of this year and the balance of 2011 to continue with similar stellar results.”
Commenting on the results, Centinel’s President, Michael D. Will, said, “There are many new and varied options available for patients and their surgeons in the treatment of spinal disc problems, however, surgeons are finding Centinel’s ground-breaking implant designs are as relevant or more-so today than when they were first introduced.”